Marinos Dalakas, MD, discusses the etiology, diagnosis, and treatment of stiff person syndrome (SPS), and the future of SPS research.

Research findings support the use of vitamin D supplementation to help slow cognitive decline in Alzheimer dementia and reduce Parkinson disease symptom severity.

These are the clinical trials that led to the FDA’s approval of aducanumab and lecanemab for early AD, plus, the concerns that loom.

Mehdi Jorfi, PhD, discusses the opportunities to optimize the development and application of neurotechnologies for AD.

Findings published in 2020 suggest that irregular sleep schedules may increase CVD risk independent of sleep quality or duration.

Danny Eckert, PhD, a researcher on human sleep and respiratory physiology, explains the potential bidirectional relationship and the clinical complications of COMISA, comorbid insomnia and sleep apnea.

Timothy S. Chang, MD, PhD and Lisa L. Barnes, PhD, discuss health disparities in ADRD and how to improve clinical outcomes for patients from underrepresented groups.

Individuals with gastroesophageal reflux disease have a higher prevalence of psychiatric disorders, which calls for a multidisciplinary approach to treatment.

The polio strain linked to 2 paralytic polio cases in New York and Israel has been found in sewage water in New York City, London, and Jerusalem.

Joseph D. Dougherty, PhD discusses genetic compounds’ ability to clear amyloid-β from the brain in patients with Alzheimer disease.